Microsoft in Talks with Broadcom for Custom AI Chips, Potentially Shifting from Marvell

Deep News
昨天

Microsoft is in discussions with Broadcom to design future custom chips, a move that could see the tech giant shift its business away from current supplier Marvell. This development highlights the strategic push by major tech companies to reduce reliance on NVIDIA amid the AI boom.

According to a report on December 5, citing sources familiar with the matter, Microsoft and Broadcom are negotiating a potential partnership for custom chip design. If finalized, Broadcom would replace Marvell as Microsoft's new collaborator in this space.

The potential deal comes as tech giants race to secure more semiconductors to expand their AI product lines. Broadcom is seen as one of the strongest competitors capable of challenging NVIDIA's dominance in the semiconductor market, thanks in part to CEO Hock Tan's preference for large-scale deals and decisive management style.

The talks reflect intensifying competition in the custom chip sector, with manufacturers vying for contracts from major tech firms. Demand for custom chips has surged as companies like Microsoft accelerate AI product development. While NVIDIA currently leads the semiconductor market, tech firms are diversifying their chip supply chains to mitigate dependence on a single supplier.

Custom chips, optimized for specific AI workloads, offer performance and cost advantages, prompting heavy investments from Microsoft, Meta, and others. Three sources involved in development revealed that Meta plans to launch its custom chip by 2027.

The report also notes that Marvell has recently waived some upfront engineering design fees to secure more business from Meta, signaling fierce competition. Broadcom, with its technical expertise and scale, is positioning itself to capture greater market share and emerge as a key challenger to NVIDIA.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10